Healthcare and Life Sciences

Who We Are

Haynes and Boone’s Healthcare, Life Sciences and Pharmaceuticals Practice Groups work with clients across all sectors of the diverse healthcare industry to address their legal needs, including business transactions, regulatory compliance, government investigations, and patent litigation and counseling.

Our Philosophy

At Haynes and Boone, we believe experience and creativity are key qualities for success in the constantly changing legal landscape of life sciences, pharmaceuticals, and healthcare. Often the best result comes from collaboration of lawyers with varied experience who together provide the right combination of knowledge and ideas for your business. Our philosophy is to use teamwork to provide our clients with innovative options to the legal opportunities in their business.

Our Experience

Our lawyers have experience in the following areas.

  • Accountable Care Organizations (ACOs)
  • Biotechnology and medical devices
  • Clinical research compliance
  • Employee benefits and executive compensation
  • False Claims Act and whistleblowers
  • Government and corporate investigations
  • Health information technology and electronic medical records
  • HIPAA/HITECH, privacy and data security
  • Managed care, health plans and insurers
  • Medicare/Medicaid reimbursement counseling and litigation
  • Patent litigation
  • Pharmaceuticals
  • Regulatory and compliance

Newsroom

Healthcare

Christopher Beinecke

The Sandbox Bully: Health Savings Accounts, Onsite Clinics, and Telemedicine

Employers, particularly those employers that feel they are running out of room to further pare down medical plan design(s) or shift cost-sharing to employees, are increasingly looking toward alternatives like telemedicine and onsite clinics to help lower the cost of their group health plans.

Newsletter

Health Law Vitals

Health Law Vitals - A Healthcare Newsletter from Haynes and Boone

The Haynes and Boone Health Law Vitals Newsletter explores significant developments and legislation in healthcare law. This edition discusses new guidance on EHR contract negotiation, the Seventh Circuit's decision to require objective standards in medical necessity cases, health savings accounts, onsite clinics, and telemedicine.

Corporate

Chemical Products Liability and Environmental Litigation

M&A May Not Cure All For Emerging Public Biotechs

While overall healthcare and biotech public M&A activity declined in 2016 relative to 2015, there were still a significant number of large transactions announced in 2016 such as Pfizer’s $14 billion acquisition of Medivation. Another trend that emerged in 2016 was the acquisition of publicly traded emerging biotech companies by larger pharma players...

Email Disclaimer